Dublin, Nov. 14, 2017 -- The "Physician Dispensed Cosmeceuticals - Global Strategic Business Report" report has been added to Research and Markets' offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Physician Dispensed Cosmeceuticals in US$ Thousand.
The Global and the US markets are further analyzed by the following Segments:
- Physician Dispensed Skin Care Products
- Physician Dispensed Eyelash Products
The report profiles 68 companies including many key and niche players such as:
- Allergan Plc (Ireland)
- SkinMedica, Inc. (USA)
- Athena Cosmetics, Inc. (USA)
- Biopelle, Inc. (USA)
- Clinique Laboratories, LLC (USA)
- iS CLINICAL (USA)
- Jan Marini Skin Research, Inc. (USA)
- La Roche-Posay Laboratoire Pharmaceutique (France)
- Neutrogena Corp. (USA)
- Obagi Medical Products, Inc. (USA)
- Pacific Bioscience Laboratories, Inc. (USA)
- SkinCeuticals (USA)
- Solta Medical, Inc. (USA)
- Stiefel Laboratories, Inc. (USA)
- ZO Skin Health, Inc. (USA)
Key Topics Covered:
1. INDUSTRY OVERVIEW
Physician Dispensed Cosmeceuticals: Delivering Health and Beauty
Asia-Pacific to Witness Strong Growth in the Future
Physician Dispensed Skin Care Products Gain Traction
Competitive Landscape
2. GROWTH DRIVERS AND MARKET TRENDS
Mid-Life Crisis
A Key Growth Driver
Cosmeceutical Consumers: A Highly Informed, Aesthetically- Conscious Group
Natural Ingredients Gain Attention
What's Next in Ingredients?
Women Account for Highest Spends on Skin Care
Customized Solutions for Uninsured Patients to go a Long Way
Physician Dispensed Cosmeceuticals
A Potential Path to Invasive Procedures
Post Procedure Topical Products in Demand
Physician Dispensing Outsmarts Conventional Retail Brands
Manufacturers Widen Customer Base
Innovative Ingredients Gain Focus
Anti-Aging Products: The Largest Segment in Skin Care Cosmeceuticals
Major Anti-Aging Ingredients of Cosmeceuticals
Major Anti-Aging Ingredients of Cosmeceuticals
Popular Cosmeceutical Contents
Stem Cell Technology: The New Frontier
Skin Brightening and Lightening Products
A High Growth Market
Companies Focus on Complementary Products
Possible Ban on Hydroquinone Stimulates Search for Other Pigment Control Products
3. AN INSIGHT INTO MARKET BARRIERS
Debate Surrounding Physician Dispensing of Cosmeceuticals
Ethical Perspective
Product Efficacy
Emergence of Medispas
Patient Discretion and Requirement
Challenges in Determining the Right Product
4. DISTRIBUTION SCENARIO
E-Commerce to Reinforce Sales of Physician Dispensed Products
Social Networking
A New Marketing Tool
5. AESTHETICS MARKET: A BRIEF INSIGHT
A Prelude
Historical and Recent Past Perspective
Aging Population: A Weighty Demographic Driver
Societal Pressure to Look Young Peps Demand for Facial Aesthetics
Undesirable Side Effects: A Challenge to Reckon With
6. PRODUCT OVERVIEW
Introduction to Cosmeceuticals
Physician Dispensed Cosmeceuticals
Physician Dispensed Skin Care Products
Physician Dispensed Eyelash Products
Skin Care Products
An Overview
Moisturizers
Nourishers/Anti-Agers
Facial Cleansers
Sun Care Products
Skin Lightening Products
Scar Repair Products
An Insight into Key Ingredients
Antioxidants
Hydroxy Acids (poly, beta, alpha)
Lightening Agents
Botanicals/Plant Extracts
Proteins/Peptides
Retinoids
OTC Retinoids
Niacinamide
Topical Peptides
N-Acetyl Glucosamine
7. RECENT INDUSTRY ACTIVITY
Croma-Pharma and Universkin Enter into Exclusive Licensing and Distribution Agreement
Revision Skincare Introduces Nectifirm ADVANCED
ALASTIN Skincare Launches ALASTIN HydraTint ProMineral Broad Spectrum Sunscreen SPF 36
Mercellar Introduces Exuviance in Kenya
CALECIM Professional Introduces Restorative Hydration Cream
SkinMedica to Market Histogen's CCM Products
Sientra Takes Over U.S. Rights to bioCorneum Advanced Silicone Gel Scar Management Therapy
Valeant to Divest Obagi Medical Products Business
Actavis Takes Over Allergan Inc., Changes Name to Allergan Plc.
MDRejuvena Unveils New Skin Care Product Line
8. FOCUS ON SELECT GLOBAL PLAYERS
9. GLOBAL MARKET PERSPECTIVE
Total Companies Profiled: 68 (including Divisions/Subsidiaries 76)
- The United States (57)
- Canada (5)
- Europe (11)
- France (5)
- Germany (2)
- The United Kingdom (1)
- Rest of Europe (3)
- Asia-Pacific (Excluding Japan) (2)
- Africa (1)
For more information about this report visit https://www.researchandmarkets.com/research/7lcxbc/physician
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cosmetics


American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 



